Chronic lymphocytic leukaemia: open trials in Puerto Rico

• NCT05947851

  A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  BRCR Global Puerto Rico - Hato Rey (Site 3901), San Juan · Auxilio Mutuo Cancer Center (Site 3900), San Juan

  Registry updated 2026-11-06

• NCT06973187

  A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  Trial Treatment · Phase 3 · BeOne Medicines

  Auxilio Mutuo Cancer Center, San Juan

  Registry updated 2026-09-28

• NCT06428019

  A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

  Trial Treatment · Phase 3 · AbbVie

  Pan American Center for Oncology Trials /ID# 266243, Rio Piedras

  Registry updated 2026-04-09

All Chronic lymphocytic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error